Levofloxacin Infus
Levofloxacin hemihydrates
Short Description
Levofloxacin Hemihydrate contains Levofloxacin hemihydrates (equivalent to Levofloxacin) as active ingredient is available in IV infusion 500 mg/100 ml and 750 mg/150 ml.
Indications
Levofloxacin Hemihydrate is indicated for the treatment of adults (≥18 years of age) with mild, moderate and severe infections caused by susceptible bacteria:
Acute bacterial sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae or Moraxella catarrhalis.
Acute bacterial exacerbation of chronic bronchitis due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae or Moraxella catarrhalis.
Nosocomial pneumonia due to Methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, or Streptococcus pneumoniae. Adjunctive therapy should be used as clinically indicated. Where Pseudomonas aeruginosa is a documented or presumtive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended.
Community-acquired pneumonia due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila or Mycoplasma pneumoniae.
Multi Drug Resistant (MDR) Streptococcus pneumoniae isolates are strains resistant to two or more of the following antibiotics: Penicillin, second generation Cephalosporin, e.g., Cefuroxime, Macrolides, Tetracyclines and Trimethoprim/Sulfamethoxazole.
Chronic bacterial prostatitis caused by Escherichia coli, Enterococcus faecalis, or Staphylococcus epidermidis.
Complicated skin and skin structure infections.
Complicated urinary tract infections.
Acute pyelonephritis.
Specification
Usual dose in patients with normal renal function : 250 mg - 750 mg once daily depends on the type and severity of the infection and the
sensitivity of the presumed causative pathogen.
